Skip to main content

View full-text article in PMC

. 2016 Sep 5;34(6):750–759. doi: 10.1007/s10637-016-0381-4

Table 3.

Severity of peripheral sensory neuropathy in each cycle. The first dose used in each cycle is indicated in the upper column for each patient

		Cycle
Patient ID		C1	C2	C3	C4	C5	C6	C7	C8	C9	C10	C11	C12	C13	C14	C15	C16	C17	C18	C19	C20	C21
BB-001	mg/m²	80	65	65	65
BB-001	Grade	G0	G0	G0	G0
BB-002	mg/m²	80	65	65	65	65	65	65
BB-002	Grade	G0	G0	G0	G0	G0	G0	G0
BB-003	mg/m²	80
BB-003	Grade	G0
BB-004	mg/m²	80	80	80	65	65	65	65	65	65	65
BB-004	Grade	G1	G1	G1	G1	G1	G1	G2	G2	G2	G2
BB-005	mg/m²	80	80	80	80	80	80	80	80	80	65	65	65	65	65
BB-005	Grade	G1	G1	G1	G1	G1	G1	G1	G1	G2	G1	G1	G1	G1	G2
BB-006	mg/m²	80	80	80	80
BB-006	Grade	G0	G1	G1	G1
BB-007	mg/m²	80	65	65	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50
BB-007	Grade	G0	G0	G0	G0	G0	G1	G1	G1	G1	G1	G0	G0	G0	G0	G0	G0	G0	G0	G1	G1	G1
BB-008	mg/m²	80	65	50	50	50	50	50
BB-008	Grade	G1	G1	G0	G0	G0	G0	G0
BB-009	mg/m²	80	80	80	80	80	65	65	65	65	65	65	65	65
BB-009	Grade	G0	G0	G0	G1	G1	G1	G1	G1	G1	G1	G1	G1	G1
BB-010	mg/m²	80	80	80	80
BB-010	Grade	G1	G1	G1	G1